NeoGenomics launches FDA-approved PTEN diagnostic test for prostate cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. SPY
3. IONS
4. ROIV
5. AAPL
6. ACN
7. AZN
8. ORCL
9. HOOD
10. QCOM

Go back to NeoGenomics launches FDA-approved PTEN diagnostic test for prostate cancer
NEOGENOMICS (NASDAQ: NEO) Delayed: 17.54 +0.16 (0.92%)
Previous Close $17.38    52 Week High $9.54 
Open $17.15    52 Week Low $5.49 
Day High $17.60    P/E 438.50 
Day Low $16.95    EPS $0.04 
Volume 333,162